Literature DB >> 26325449

Conventional and robust norming in identifying preclinical dementia.

Ellen Grober1, Wenzhu Mowrey2, Mindy Katz1, Carol Derby1, Richard B Lipton1,2.   

Abstract

OBJECTIVE: To contrast four approaches to norming two widely used memory tests in older adults for the purpose of detecting preclinical dementia.
METHOD: The study sample included participants from the Einstein Aging Study who were over age 70, were free of dementia at baseline, and were followed for at least 5 years. Norms were derived from a conventional sample (excluding individuals with dementia at baseline but not those who developed dementia during follow-up) and a robust normative sample (excluding persons with dementia at baseline as well as those who developed dementia over 5 years of follow-up). Both normative samples were examined with and without adjustment for age and education. We contrasted the picture version of the Free and Cued Selective Reminding Test with Immediate Recall (pFCSRT+IR) and the Logical Memory (LM) test for their ability to identify persons with preclinical dementia, operationally defined by the development of diagnosable dementia over 5 years of follow-up, using these four approaches to developing norms for detecting preclinical dementia.
RESULTS: Of 418 participants included in the conventional normative sample, the mean age was 78.2 years, and 59% were female. There were 78 incident cases of dementia over 5 years leaving 340 participants in the robust normative sample. Means and standard deviations were defined for both the conventional and robust normative samples, and cut-scores with and without adjustment were set at 1.5 standard deviations below the mean of each test. As predicted, in comparison with the conventional sample, the robust sample had higher cut-scores, which provided higher sensitivity for detecting preclinical dementia. This effect persisted regardless of adjustment. The pFCSRT+IR was more sensitive than LM in detecting incident dementia cases.
CONCLUSION: When using cognitive test norms to identify preclinical dementia, robust norming procedures improves detection using both the pFCSRT+IR and LM.

Entities:  

Keywords:  Free and Cued Selective Reminding Test; Incident dementia; Logical memory; Memory; Mild cognitive impairment; Preclinical dementia; Robust and conventional norms

Mesh:

Year:  2015        PMID: 26325449      PMCID: PMC6790124          DOI: 10.1080/13803395.2015.1078779

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  22 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

3.  Effective normative samples for the detection of cognitive impairment in older adults.

Authors:  L J Ritchie; R J Frerichs; H Tuokko
Journal:  Clin Neuropsychol       Date:  2007-12       Impact factor: 3.535

4.  Screening older Latinos for dementia in the primary care setting.

Authors:  Ellen Grober; Amy R Ehrlich; Yaritza Troche; Steven Hahn; Richard B Lipton
Journal:  J Int Neuropsychol Soc       Date:  2014-08-14       Impact factor: 2.892

5.  Free and cued selective reminding identifies very mild dementia in primary care.

Authors:  Ellen Grober; Amy E Sanders; Charles Hall; Richard B Lipton
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jul-Sep       Impact factor: 2.703

6.  Prognosis of mild cognitive impairment in general practice: results of the German AgeCoDe study.

Authors:  Hanna Kaduszkiewicz; Marion Eisele; Birgitt Wiese; Jana Prokein; Melanie Luppa; Tobias Luck; Frank Jessen; Horst Bickel; Edelgard Mösch; Michael Pentzek; Angela Fuchs; Sandra Eifflaender-Gorfer; Siegfried Weyerer; Hans-Helmut König; Christian Brettschneider; Hendrik van den Bussche; Wolfgang Maier; Martin Scherer; Steffi G Riedel-Heller
Journal:  Ann Fam Med       Date:  2014 Mar-Apr       Impact factor: 5.166

7.  Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study.

Authors:  Mindy J Katz; Richard B Lipton; Charles B Hall; Molly E Zimmerman; Amy E Sanders; Joe Verghese; Dennis W Dickson; Carol A Derby
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Oct-Dec       Impact factor: 2.703

8.  Free and cued selective reminding test: MOANS norms.

Authors:  R J Ivnik; G E Smith; J A Lucas; E G Tangalos; E Kokmen; R C Petersen
Journal:  J Clin Exp Neuropsychol       Date:  1997-10       Impact factor: 2.475

9.  Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.

Authors:  Jesus J Gomar; Maria T Bobes-Bascaran; Concepcion Conejero-Goldberg; Peter Davies; Terry E Goldberg
Journal:  Arch Gen Psychiatry       Date:  2011-09

10.  Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

Authors:  Liesi E Hebert; Jennifer Weuve; Paul A Scherr; Denis A Evans
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

View more
  6 in total

1.  Two-stage screening for early dementia in primary care.

Authors:  Ellen Grober; Wenzhu Bi Mowrey; Amy R Ehrlich; Peter Mabie; Steven Hahn; Richard B Lipton
Journal:  J Clin Exp Neuropsychol       Date:  2016-06-07       Impact factor: 2.475

2.  Vertical Jump Tests: A Safe Instrument to Improve the Accuracy of the Functional Capacity Assessment in Robust Older Women.

Authors:  Carlos A F Santos; Gislene R Amirato; Alessandro F Jacinto; Ana V Pedrosa; Adriana Caldo-Silva; António R Sampaio; Nuno Pimenta; Juliana M B Santos; Alberto Pochini; André L L Bachi
Journal:  Healthcare (Basel)       Date:  2022-02-08

3.  Mayo normative studies: A conditional normative model for longitudinal change on the Auditory Verbal Learning Test and preliminary validation in preclinical Alzheimer's disease.

Authors:  Eva C Alden; Emily S Lundt; Erin L Twohy; Teresa J Christianson; Walter K Kremers; Mary M Machulda; Clifford R Jack; David S Knopman; Michelle M Mielke; Ronald C Petersen; Nikki H Stricker
Journal:  Alzheimers Dement (Amst)       Date:  2022-07-15

4.  Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illness.

Authors:  Karra D Harrington; Yen Ying Lim; David Ames; Jason Hassenstab; Simon M Laws; Ralph N Martins; Stephanie Rainey-Smith; Joanne Robertson; Christopher C Rowe; Olivier Salvado; Vincent Doré; Victor L Villemagne; Peter J Snyder; Colin L Masters; Paul Maruff
Journal:  Alzheimers Dement (Amst)       Date:  2017-06-09

5.  The age-related effect on cognitive performance in cognitively healthy elderly is mainly caused by underlying AD pathology or cerebrovascular lesions: implications for cutoffs regarding cognitive impairment.

Authors:  Emma Borland; Erik Stomrud; Danielle van Westen; Oskar Hansson; Sebastian Palmqvist
Journal:  Alzheimers Res Ther       Date:  2020-03-24       Impact factor: 6.982

6.  Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.

Authors:  Anna Brugulat-Serrat; Alba Cañas-Martínez; Lidia Canals-Gispert; Paula Marne; Nina Gramunt; Marta Milà-Alomà; Marc Suárez-Calvet; Eider M Arenaza-Urquijo; Oriol Grau-Rivera; José María González-de-Echávarri; Carolina Minguillon; Karine Fauria; Gwendlyn Kollmorgen; Ivonne Suridjan; Henrik Zetterberg; Kaj Blennow; Juan Domingo Gispert; José Luis Molinuevo; Gonzalo Sánchez-Benavides
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.